| Website | zilico.co.uk |
| Category | BioTech |
| Phone | 44(0)114-222-4580 |
| Employees |
| TOTAL | $1.55M |
| FUNDING TOTAL | $1.55M |
| Venture Round, 6/12 North West Fund Fusion IP | £985k |
Zilico is developing the next generation of cancer diagnostics that will provide real-time diagnosis for cervical cancer and reduce the inherent subjectivity of current methods. Two applications are under development: the first for the referral market and the second for the screening market.